COVA322
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for COVA322, covering 2016-03-01 to 2016-03-01. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Tolerability Study of COVA322 in Patients With Stable Chronic Moderate-to-severe Plaque Psoriasis [Phase 1, Phase 2]